Conference Presentation Details - Table of Contents

26th Annual Miami Breast Cancer Conference
Day 4 Main Conference

Release Date: March 8, 2009| Mar 7, 2009, Miami, FL

Table of Contents

Guidelines for Preoperative Therapy: A Multidisciplinary Approach
Michael Untch

Relevance of Age and ER Status to Benefit From Preoperative Chemotherapy vs. Postoperative Chemotherapy
Norman Wolmark

Preoperative Endocrine Therapy
Matthew Ellis

How Do You Measure Residual Breast Cancer and Its Relationship to Survival: Is Residual Tumor Enhanced for Stem Cells?
William F. Symmans

Cancer Stem Cells: Opportunities for New Therapeutic Modalities
Emanuel Petricoin

What Determines the Sites of Metastases, and Is It Hardwired Into Primary Tumor?
Debu Tripathy

Response of Triple-Negative Tumors to Preoperative Chemotherapy: Prognostic Markers to Identify Tumors With More Aggressive Behavior
Lisa Carey

New Insights Into the Biology and Management of Inflammatory Breast Cancer
Hyman B. Muss

Surgical Options After Preoperative Systemic Therapy
J. Michael Dixon

Locoregional Treatments After Preoperative Chemotherapy
Timothy Whelan

Surgical Management of Lymphedema
Sumner Slavin

Panel Discussion With Case Presentations
Moderator:
Robert DerHagopian
Panel:
Alan Ashworth
Lisa Carey
Matthew Ellis
Hyman B. Muss
Emanuel Petricoin
Lajos Pusztai
Sumner Slavin
Michael Untch
Timothy Whelan
Norman Wolmark

Instructions for Participation

To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>

To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>

View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Educational Partners
  2. Genentech BioOncology
  3. GlaxoSmithKline
  4. Major Contributors
  5. AstraZeneca/Abraxis BioScience
  6. Bristol-Myers Squibb
  7. Novartis Oncology
  8. sanofi-aventis U.S.
  9. Supporters
  10. Amgen
  11. Centocor Ortho Biotech Inc.
  12. ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
  13. Honorary Supporter
  14. Joe’s Stone Crab Restaurant